Evolving Switch Scene Could Drive Nonprescription Reimbursement – Gottlieb

Drug sponsors should work with insurers in advance of nonprescription switches to develop reimbursement plans to benefit consumers, particularly when considering a behind-the-counter switch, former FDA Deputy Commissioner Scott Gottlieb advises